Clinical Trials Logo
  1. Home
  2. Acute Pain
  3. NCT04883034
  4. Details
NCT04883034 Clinical Trial

Adductor Canal Block in Outpatient Clinic for Pain Control After Knee Arthroplasty

Acute Pain Clinical Trial

— ACB  

Official title:
Adductor Canal Block in Outpatient Clinic

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04883034
Other study ID # ACB OUTPATIENT CLINIC
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2020
Est. completion date June 1, 2021

Study information
Verified date May 2021
Source Gadjah Mada University
Contact sholahuddin rhatomy, Dr
Phone +6281808720707
Email sholahuddin.rhatomy@ugm.ac.id
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Single-shot Adductor Canal Block in the outpatient clinic is safe, significantly decreased pain and analgesic consumption and may enhance the rehabilitation program

Description:

The ACB in the outpatient clinic is safe and can minimize postoperative pain. The primary goal of this research was to see how ACB affected the Visual Analog Score (VAS) pain score during the rehabilitation as opposed to controls. The secondary goal was to determine how much analgesic (etoricoxibe) was consumed on a daily basis.

Recruitment information / eligibility
Status Recruiting
Enrollment 60
Est. completion date June 1, 2021
Est. primary completion date June 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 65 Years
Eligibility Inclusion Criteria: - Indonesian or Javanese-speaking adults - After perfomed total knee replacement - American Society of Anesthesiologists physical status I-III - body mass index (BMI) of 18-40 kg/m2 Exclusion Criteria: - Declined to complete the study - Unable to cooperate - had an allergic reaction to any of the drugs - abusing alcohol or drugs

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• adductor canal block in outpatient clinic
perform adductor canal block in outpatient clinic for patient post total knee arthroplasty
Drug:
• Analgesics, etoricoxibe
anaelgetic oral intake

Locations
Country Name City State
Indonesia Sholahuddin Rhatomy Sleman Yogyakarta

Sponsors (1)
Lead Sponsor Collaborator
Gadjah Mada University

Country where clinical trial is conducted

Indonesia, 

Outcome
Type Measure Description Time frame Safety issue
Primary Visual analog pain score (VAS) A VAS scale was used to assess pain severity, with 0 indicating no pain and 10 indicating extreme pain one month
Secondary analgesic oral intake (etoricoxibe) determine how much analgesic (etoricoxibe) was consumed on a daily basis. one month
See also
  Status Clinical Trial Phase
Completed NCT04484610 - Appropriate Opioid Quantities for Acute Pain - Pharmacist Study Phase 4
Recruiting NCT05054179 - Pecto-Intercostal Fascial Plane Block Catheter Trial for Reduction of Sternal Pain Phase 2/Phase 3
Completed NCT04548635 - VR for Burn Dressing Changes at Home Phase 2/Phase 3
Recruiting NCT05370404 - Prescribing vs. Recommending Over-The-Counter (PROTECT) Analgesics for Patients With Postoperative Pain: N/A
Completed NCT06054945 - Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
Completed NCT03825549 - A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing N/A
Completed NCT05995912 - Efficacy and Safety of Etoricoxib-tramadol Tablet in Acute Postoperative Pain Phase 2
Recruiting NCT05589246 - Regional Analgesia in Combination With Cryoanalgesia to Prevent Acute Pain Following Nuss Procedure N/A
Recruiting NCT05572190 - Evaluate the Safety and Pharmacokinetic Profile of ETR028 and ETR029 in Healthy Adult Subjects Phase 1
Terminated NCT04716413 - Evaluating the Use of Sublingual Sufentanil in Patients With Suboxone Treatment Phase 4
Active, not recruiting NCT03537573 - Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care N/A
Not yet recruiting NCT06317844 - Examination of Psychological and Physiological Pathways Linking Gratitude and Pain N/A
Withdrawn NCT02957097 - Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures Phase 4
Completed NCT02565342 - Interscalene Brachial Plexus Block to Treat Pain After Clavicular Surgery Phase 4
Terminated NCT02599870 - Clinical Study to Evaluate Clinical Impact of PGx-Guided Treatment for Patients Undergoing Elective Spinal Surgical Procedures N/A
Completed NCT02984098 - 40% Orally Administered Dextrose Gel is More Effective Than 25% Dextrose Phase 4
Completed NCT02380989 - Integrative Ayurveda Healing Relieves Minor Sports Injury Pain Phase 2
Completed NCT02489630 - Low Dose Ketamine as an Adjunct to Opiates for Acute Pain in the Emergency Department Phase 4
Completed NCT03107338 - Preventive Treatment of Pain After Dental Implant Surgery Phase 4
Completed NCT02817477 - Intranasal Ketamine for Acute Traumatic Pain Phase 4